AIRS vs. PNTG, CDNA, AGL, FLGT, LFMD, TALK, INNV, EHAB, SBC, and AUNA
Should you be buying AirSculpt Technologies stock or one of its competitors? The main competitors of AirSculpt Technologies include The Pennant Group (PNTG), CareDx (CDNA), agilon health (AGL), Fulgent Genetics (FLGT), LifeMD (LFMD), Talkspace (TALK), InnovAge (INNV), Enhabit (EHAB), SBC Medical Group (SBC), and Auna (AUNA). These companies are all part of the "healthcare" industry.
AirSculpt Technologies vs. Its Competitors
The Pennant Group (NASDAQ:PNTG) and AirSculpt Technologies (NASDAQ:AIRS) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, valuation, community ranking, analyst recommendations, earnings, institutional ownership, risk, dividends and media sentiment.
The Pennant Group received 32 more outperform votes than AirSculpt Technologies when rated by MarketBeat users. Likewise, 46.24% of users gave The Pennant Group an outperform vote while only 35.48% of users gave AirSculpt Technologies an outperform vote.
The Pennant Group has a net margin of 3.24% compared to AirSculpt Technologies' net margin of -4.13%. The Pennant Group's return on equity of 13.47% beat AirSculpt Technologies' return on equity.
85.9% of The Pennant Group shares are held by institutional investors. Comparatively, 91.5% of AirSculpt Technologies shares are held by institutional investors. 5.4% of The Pennant Group shares are held by insiders. Comparatively, 76.6% of AirSculpt Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
The Pennant Group has higher revenue and earnings than AirSculpt Technologies. AirSculpt Technologies is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks.
The Pennant Group has a beta of 1.51, meaning that its stock price is 51% more volatile than the S&P 500. Comparatively, AirSculpt Technologies has a beta of 2.47, meaning that its stock price is 147% more volatile than the S&P 500.
The Pennant Group currently has a consensus target price of $34.60, suggesting a potential upside of 24.73%. AirSculpt Technologies has a consensus target price of $3.75, suggesting a potential downside of 28.57%. Given The Pennant Group's stronger consensus rating and higher possible upside, equities analysts plainly believe The Pennant Group is more favorable than AirSculpt Technologies.
In the previous week, AirSculpt Technologies had 2 more articles in the media than The Pennant Group. MarketBeat recorded 8 mentions for AirSculpt Technologies and 6 mentions for The Pennant Group. The Pennant Group's average media sentiment score of 0.87 beat AirSculpt Technologies' score of 0.15 indicating that The Pennant Group is being referred to more favorably in the media.
Summary
The Pennant Group beats AirSculpt Technologies on 13 of the 18 factors compared between the two stocks.
Get AirSculpt Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for AIRS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding AIRS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
AirSculpt Technologies Competitors List
Related Companies and Tools
This page (NASDAQ:AIRS) was last updated on 6/12/2025 by MarketBeat.com Staff
Buy AIRS Stock Free AIRS Stock Alerts